髄膜炎菌性疾患薬市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Type (2020-2025)
1.3.2 Injectable
1.3.3 Oral
1.4 Market Segment by Application
1.4.1 Global Meningococcal Disease Drugs Market Share by Application (2020-2025)
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Meningococcal Disease Drugs Market Size
2.1.1 Global Meningococcal Disease Drugs Revenue 2015-2025
2.1.2 Global Meningococcal Disease Drugs Sales 2015-2025
2.2 Meningococcal Disease Drugs Growth Rate by Regions
2.2.1 Global Meningococcal Disease Drugs Sales by Regions 2015-2019
2.2.2 Global Meningococcal Disease Drugs Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Meningococcal Disease Drugs Sales by Manufacturers
3.1.1 Meningococcal Disease Drugs Sales by Manufacturers 2015-2019
3.1.2 Meningococcal Disease Drugs Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Meningococcal Disease Drugs Revenue by Manufacturers (2015-2019)
3.2.2 Meningococcal Disease Drugs Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Meningococcal Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Meningococcal Disease Drugs Price by Manufacturers
3.4 Key Manufacturers Meningococcal Disease Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Meningococcal Disease Drugs Market
3.6 Key Manufacturers Meningococcal Disease Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Injectable Sales and Revenue (2015-2019)
4.1.2 Oral Sales and Revenue (2015-2019)
4.2 Global Meningococcal Disease Drugs Sales Market Share by Type
4.3 Global Meningococcal Disease Drugs Revenue Market Share by Type
4.4 Meningococcal Disease Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Meningococcal Disease Drugs Sales by Application

6 United States
6.1 United States Meningococcal Disease Drugs Breakdown Data by Company
6.2 United States Meningococcal Disease Drugs Breakdown Data by Type
6.3 United States Meningococcal Disease Drugs Breakdown Data by Application

7 European Union
7.1 European Union Meningococcal Disease Drugs Breakdown Data by Company
7.2 European Union Meningococcal Disease Drugs Breakdown Data by Type
7.3 European Union Meningococcal Disease Drugs Breakdown Data by Application

8 China
8.1 China Meningococcal Disease Drugs Breakdown Data by Company
8.2 China Meningococcal Disease Drugs Breakdown Data by Type
8.3 China Meningococcal Disease Drugs Breakdown Data by Application

9 Rest of World
9.1 Rest of World Meningococcal Disease Drugs Breakdown Data by Company
9.2 Rest of World Meningococcal Disease Drugs Breakdown Data by Type
9.3 Rest of World Meningococcal Disease Drugs Breakdown Data by Application
9.4 Rest of World Meningococcal Disease Drugs Breakdown Data by Countries
9.4.1 Rest of World Meningococcal Disease Drugs Sales by Countries
9.4.2 Rest of World Meningococcal Disease Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
10.1.4 Meningococcal Disease Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
10.2.4 Meningococcal Disease Drugs Product Introduction
10.2.5 GlaxoSmithKline Recent Development
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
10.3.4 Meningococcal Disease Drugs Product Introduction
10.3.5 Sanofi Pasteur Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Meningococcal Disease Drugs
10.4.4 Meningococcal Disease Drugs Product Introduction
10.4.5 Novartis Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Meningococcal Disease Drugs Sales Channels
11.2.2 Meningococcal Disease Drugs Distributors
11.3 Meningococcal Disease Drugs Customers

12 Market Forecast
12.1 Global Meningococcal Disease Drugs Sales and Revenue Forecast 2020-2025
12.2 Global Meningococcal Disease Drugs Sales Forecast by Type
12.3 Global Meningococcal Disease Drugs Sales Forecast by Application
12.4 Meningococcal Disease Drugs Forecast by Regions
12.4.1 Global Meningococcal Disease Drugs Sales Forecast by Regions 2020-2025
12.4.2 Global Meningococcal Disease Drugs Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer